CNK Stock Analysis: Cinemark Holdings | NYSE
Entertainment | NYSE, USA | Market Cap: 4.222m USD | 12M Return: 53.1% | US17243V1026 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 71.3M
EPS Trend: 28.6%
Qual. Beats: 0
Rev. Trend: 69.2%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Cinemark Holdings, Inc. (NYSE: CNK) is a U.S.-based movie theatre operator founded in 1984 and headquartered in Plano, Texas. The company runs a theatrical exhibition business with locations across the United States and Latin America, having completed its IPO in 2007. As a member of the Communication Services sector within the Movies & Entertainment sub-industry, Cinemarks revenue is driven primarily by box office ticket sales, concessions (food and beverages), and on-screen advertising, with its results closely tied to the film release slate and consumer attendance trends.
- Blockbuster film slate drives box office recovery
- Latin America segment expands international revenue growth
- Streaming competition pressures theatrical attendance and concession margins
| Net Income: 216.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.24 > 1.0 |
| NWC/Revenue: -5.88% < 20% (prev 13.45%; Δ -19.33% < -1%) |
| CFO/TA 0.09 > 3% & CFO 579.0m > Net Income 216.0m |
| Net Debt (2.50b) to EBITDA (607.8m): 4.11 < 3 |
| Current Ratio: 0.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (116.6m) vs 12m ago -21.80% < -2% |
| Gross Margin: 29.98% > 18% (prev 64.08%; Δ -34.10% > 0.5%) |
| Asset Turnover: 58.90% > 50% (prev 64.51%; Δ -5.60% > 0%) |
| Interest Coverage Ratio: 2.85 > 6 (EBIT TTM 401.6m / Interest Expense TTM 141.0m) |
| A: -0.03 (Total Current Assets 703.2m - Total Current Liabilities 901.0m) / Total Assets 6.43b |
| B: 0.01 (Retained Earnings 47.1m / Total Assets 6.43b) |
| C: 0.07 (EBIT TTM 401.6m / Avg Total Assets 5.71b) |
| D: 0.47 (Book Value of Equity 2.06b / Total Liabilities 4.36b) |
| Altman-Z'' = 0.79 = B |
| DSRI: 1.21 (Receivables 286.9m/226.9m, Revenue 3.36b/3.22b) |
| GMI: 2.14 (GM 64.08% / 29.98%) |
| AQI: 2.09 (AQ_t 0.71 / AQ_t-1 0.34) |
| SGI: 1.05 (Revenue 3.36b / 3.22b) |
| TATA: -0.06 (NI 216.0m - CFO 579.0m) / TA 6.43b) |
| Beneish M = -1.15 (Cap -4..+1) = D |
As of October 14, 2026, the stock is trading at USD 37.94 with a total of 1,479,203 shares traded. Over the past week, the price has changed by +7.54%, over one month by +8.93%, over three months by +30.47% and over the past year by +53.07%.
Current recommended Stop Loss: 35.60 (which is 6.2% or 2 ATR below the current price).
Cinemark Holdings has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CNK.
- StrongBuy: 5
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 39.8 | 5% |
P/E Trailing = 19.5806
P/E Forward = 13.5501
P/S = 1.2552
P/B = 8.3689
P/EG = 1.7222
Revenue TTM = 3.36b USD
EBIT TTM = 401.6m USD
EBITDA TTM = 607.8m USD
Long Term Debt = 1.87b USD (from longTermDebt, last quarter)
Short Term Debt = 191.1m USD (from shortTermDebt, last quarter)
Debt = 3.00b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.09b
Net Debt = 2.50b USD (calculated: Debt 3.00b - CCE 504.3m)
Enterprise Value = 6.72b USD (4.22b + Debt 3.00b - CCE 504.3m)
Interest Coverage Ratio = 2.85 (Ebit TTM 401.6m / Interest Expense TTM 141.0m)
EV/FCF = 21.46x (Enterprise Value 6.72b / FCF TTM 313.0m)
FCF Yield = 4.66% (FCF TTM 313.0m / Enterprise Value 6.72b)
FCF Margin = 9.31% (FCF TTM 313.0m / Revenue TTM 3.36b)
Net Margin = 6.42% (Net Income TTM 216.0m / Revenue TTM 3.36b)
Gross Margin = 29.98% ((Revenue TTM 3.36b - Cost of Revenue TTM 2.35b) / Revenue TTM)
Gross Margin QoQ = 51.26% (prev 20.98%)
Tobins Q-Ratio = 1.04 (Enterprise Value 6.72b / Total Assets 6.43b)
Interest Expense / Debt = 4.70% (Interest Expense 141.0m / Debt 3.00b)
Taxrate = 16.32% (43.0m / 263.4m)
NOPAT = 336.0m (EBIT 401.6m * (1 - 16.32%))
Current Ratio = 0.78 (Total Current Assets 703.2m / Total Current Liabilities 901.0m)
Debt / Equity = 1.46 (Debt 3.00b / totalStockholderEquity, last quarter 2.06b)
Debt / EBITDA = 4.11 (Net Debt 2.50b / EBITDA 607.8m)
Debt / FCF = 7.97 (Net Debt 2.50b / FCF TTM 313.0m)
Total Stockholder Equity = 807.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.78% (Net Income 216.0m / Total Assets 6.43b)
RoE = 26.76% (Net Income TTM 216.0m / Total Stockholder Equity 807.1m)
RoCE = 15.00% (EBIT 401.6m / Capital Employed (Equity 807.1m + L.T.Debt 1.87b))
RoIC = 6.05% (NOPAT 336.0m / Invested Capital 5.55b)
WACC = 4.87% (E(4.22b)/V(7.22b) * Re(5.54%) + D(3.00b)/V(7.22b) * Rd(4.70%) * (1-Tc(0.16)))
Discount Rate = 5.54% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -81.40 | Cagr: -11.22%
[DCF] Terminal Value 75.79% ; FCFF base≈309.7m ; Y1≈318.0m ; Y5≈352.0m
[DCF] Fair Price = 25.49 (EV 5.45b - Net Debt 2.50b = Equity 2.95b / Shares 115.9m; r=8.35% [WACC [floored]]; 5y FCF grow 2.69% → 2.50% )
EPS Correlation: 28.60 | EPS CAGR: 12.26% | SUE: 0.66 | # QB: 0
Revenue Correlation: 69.20 | Revenue CAGR: 3.76% | SUE: 3.70 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.80 | Chg30d=+17.28% | Revisions=+57% | Analysts=9
EPS current Year (2026-12-31): EPS=2.50 | Chg30d=+6.66% | Revisions=+57% | GrowthEPS=+140.8% | GrowthRev=+15.4%
EPS next Year (2027-12-31): EPS=2.73 | Chg30d=+2.58% | Revisions=+57% | GrowthEPS=+9.1% | GrowthRev=+2.4%
[Analyst] Revisions Ratio: +80% (up=12, down=0)